医脉通中期报告2024

Medlive Technology Co., Ltd. (Incorporated in the Cayman Islands with limited liability) Stock Code: 2192 Interim Report2024中期 報告 Contents目錄 Corporate Information Business Overview and Outlook4 Management Discussion and Analysis18 Unaudited Interim Condensed Consolidated Statement of Profit or Loss andOther Comprehensive Income29 Unaudited Interim Condensed Consolidated Statement of Financial Position31 Unaudited Interim Condensed Consolidated Statement of Changes in Equity33 Notes to Unaudited Interim Condensed Consolidated Financial Information37 Other Information56 Corporate Information公司資料 BOARD OF DIRECTORSExecutive Directors Ms. Tian Liping(Chairwoman and Chief Executive Officer)Mr. Tian Lixin(President)Mr. Tian LijunMs. Zhou Xin Non-Executive Directors Mr. Eiji TsuchiyaMr. Kazutaka Kanairo Independent Non-Executive Directors Mr. Richard YehDr. Ma JunMs. Wang Shan AUDIT COMMITTEE Ms. Wang Shan(Chairwoman)Mr. Richard YehDr. Ma Jun NOMINATION COMMITTEE Ms. Tian Liping(Chairwoman)Mr. Richard YehDr. Ma JunMs. Wang Shan REMUNERATION COMMITTEE Mr. Richard Yeh(Chairman)Dr. Ma JunMs. Wang Shan 20247 15 COMPANY SECRETARY Ms. Yang YanlingMs. Chu Cheuk Ting(resigned with effect from 15 July 2024) 1617 HONG KONG SHARE REGISTRAR Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong REGISTERED OFFICE IN THE CAYMAN ISLANDS PO Box 309Ugland HouseGrand CaymanKY1–1104Cayman Islands PO Box 309Ugland HouseGrand CaymanKY1–1104Cayman Islands Corporate Information公司資料 AUTHORIZED REPRESENTATIVES 20247 1520247 15 Mr. Tian LijunMs. Chu Cheuk Ting(resigned with effect from 15 July 2024)Ms. Yang Yanling(appointed with effect from 15 July 2024) AUDITOR 97927 Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong www.medlive.cn COMPANY’S WEBSITEwww.medlive.cn 2192 STOCK CODE2192 HEADQUARTERS IN THE PRC 1E1 E1Red Manor International Bonded Innovation ParkNo. 1 Baijialou Chaoyang North RoadChaoyang District, BeijingPRC CAYMAN ISLANDS PRINCIPAL SHARE REGISTRARAND TRANSFER OFFICE Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands Maples Fund Services (Cayman) LimitedPO Box 1093, Boundary HallCricket SquareGrand Cayman KY1-1102Cayman Islands PRINCIPAL PLACE OF BUSINESS IN HONG KONG 31/F., Tower Two, Times Square1 Matheson StreetHong Kong 131 PRINCIPAL BANKS Bank of Beijing Co., Ltd.The Industrial Bank Co., Ltd.China CITIC Bank Corporation LimitedDBS Bank (China) LimitedChina CITIC Bank International LimitedDBS Bank (Hong Kong) LimitedPing An Bank Co., Ltd.Bank of China (Hong Kong) LimitedChina Merchants Bank Co., Ltd. Business Overview and Outlook業務概覽及展望 BUSINESS REVIEW In the first half of 2024, the pace of deepening medical reformin China has accelerated. At the beginning of the year, the StateCouncil clearly put forward the strategic goal of promoting thesynergistic development and governance of medical insurance,medical care and medicine in the Report on the Work of theGovernment (). This June, the General Office ofthe State Council issued the Key Tasks for Deepening Medicaland Health System Reform in 2024 (2024), and placed emphasis on various tasks,includingthe strengthening of the leadership of the medicalreform organization, the in-depth promotion of the experienceof the Sanming medical reform, the further improvement of themedicaland health service system,the deepening of reformand innovation in the field of drugs, and the promotion of digitalempowerment of medical reform. This series of policy guidancehasinjected new vitality into the healthy development of themedicalindustry.On the other hand,medical anti-corruptionhasbecome institutionalized and normalized,which playedasignificant role in promoting the sustainable and favorableinnovation and development of the industry. In this context, asa leader in the field of digital medical marketing, Medlive hasenjoyed significant benefits from such policies and ushered inits golden period of business development. 202462024 TheGroup actively responded to the call of the countr y,andprovided high-quality professional medical content andclinical decision support tools for physicians in China throughcontinuoustechnological innovation and service optimization.Wea l s o p rov i d e d p h a r m a c e u t i c a l a n d m e d i c a l d e v i c ecompanieswith efficient precise digital academic educationsolutions for physicians. Our products and solutions not onlyempoweredphysicians to improve their clinical diagnosisandtreatment standard and helped the implementation ofgradeddiagnosis and treatment,but also promoted theinnovativepractice of academic education for physicians bypharmaceutical and medical device companies. Our productsand solutions have improved marketing efficiency, and continuedto contribute to the innovation and development of the medicalind